About Us
Overview
Leadership
Facility and Equipment
Quality and Compliance
Therapeutic Areas
Why Us?
Values
Process
Partners
Careers
About UsOverviewLeadershipFacility and EquipmentQuality and ComplianceTherapeutic AreasWhy Us?ValuesProcessPartnersCareers
Our scientists use effective method development validation techniques to identify, separate, and quantify drugs and metabolites in biological fluids. A Method Development Validation Lab ensures that all processes adhere to strict quality standards for preclinical and clinical trials. Here’s how we can support your study:
Method Development is the process of selecting and optimizing analytical methods to measure specific attributes of a drug substance or drug product. This process ensures that methods provide accurate, reliable, and reproducible results. Key considerations include sample preparation, instrument settings, and analyte stability. Analytical method development and validation plays a critical role in maintaining a drug’s identity, purity, potency, and stability throughout its lifecycle.
A Method Development Validation Lab is essential in this process to ensure the accuracy and reliability of the methods developed. The lab specializes in creating optimized methods for drug testing, ensuring compliance with regulatory standards.
Method Transfer, on the other hand, refers to the process of transferring an analytical method from one laboratory to another or from one piece of equipment to another. This ensures consistency across different labs or locations, especially when multiple testing sites are involved in drug development.
Connect With Us For A Reference Call With Them!
“NorthEast BioLab is the most responsive and thorough bioanalysis lab services CRO.”
“NorthEast BioLab is a responsive, collaborative, and reliable partner.”
“We trust NorthEast BioLab to design and execute streamlined, impactful bioanalytical projects.”
We found their integrity as refreshing as readiness to provide creative scientific input and high-quality data.
We have worked with NorthEast BioLab for over ten years given their commitment to highest quality bioanalytical data.
NorthEast BioLab tremendously supported us in reproducing our critical lab discoveries for drug metabolism.
NorthEast BioLab always exceeds expectations on bioanalytical assay development, validation, and sample analysis.
“NorthEast BioLab goes the extra mile. We look forward to more meaningful collaborations.”
“NorthEast BioLab offers a science-based, hands-on approach to the latest bioanalytical platforms.”
We are thrilled to complete our bioanalytical studies with their top quality and incredibly responsive team.
We worked closely to implement the most efficient and cost-effective bioanalytical assay for our PK Studies.
Our projects with NorthEast BioLab include successful method development, validation, stability studies during Clinical Phase I – IV studies.
NorthEast BioLab provides critical insight, and are compliant with regulatory standards and industry best practices. We highly recommend them and look forward to working together again.
Our latest successful study was a pivotal bioequivalence study, where samples from a cross-over study with about 100 volunteers needed swift analysis.
This study, same as all other bioanalytical studies, was completed with top quality and reporting standard with incredible responsiveness.
“NorthEast BioLab’s scientists deliver high-quality data on time and within budget.”
Method Validation confirms that an analytical method is suitable for its intended use and produces reliable results over time. It follows guidelines from regulatory bodies such as the FDA and ICH, ensuring that methods comply with regulatory standards. This process evaluates key parameters such as specificity, accuracy, precision, and sensitivity.
A Method Development Validation Lab ensures that method validation is executed with precision, providing sponsors confidence in the methods used for drug testing. Additionally, analytical method development and validation procedures ensure that the process adheres to all necessary guidelines for quality and compliance.
Partial Validation is used when modifications are made to a previously validated method. It covers only the modified aspects, ensuring that the changes do not affect the reliability of the results.
Cross-validation involves comparing results from two or more analytical methods to ensure consistency across different laboratories, instruments, or matrices. It is a crucial part of method transfer and ensures the method’s robustness.
We follow these key steps to ensure successful analytical method development and validation:
Establish the critical quality attributes (CQAs) of the drug and the acceptance criteria for the method.
A comprehensive review of scientific literature and regulatory standards to set a baseline.
Select reference standards, instrumentation, and experimental design.
Ensure sensitivity and robustness to meet performance requirements.
Rigorous testing of linearity, range, LOD, and LOQ to ensure the method is reliable.
Analytical method development and validation procedures are critical to ensure that selected methods can handle different drug properties and meet regulatory requirements with precision and accuracy. Working with a Method Development Validation Lab ensures these steps are followed meticulously, ensuring compliance with all regulatory standards.
Bioanalysis is an essential tool in drug discovery and development for determining the concentration of drugs and their metabolites in biological matrices. Bioanalytical methods such as LC-MS and ELISA are routinely used to support pharmacokinetics and drug metabolism studies. Precise quantitation of drug and metabolite concentrations is crucial for understanding pharmacokinetics, drug-drug interactions, and safety profiles…..
Sample analysis for Good Laboratory Practice (GLP) studies is a critical component of bioanalysis. This phase involves developing protocols, sample handling, and analysis under strict regulatory guidelines. Depending on the development phase, sample analysis can be performed under R&D or cGMP conditions. Our laboratory employs high-precision instrumentation, such as LC-MS and ELISA, to ensure reliable and reproducible results throughout drug development.
In GLP studies, the following aspects are crucial for the sample analysis protocol:
The final step in the method development validation process involves developing a protocol and conducting sample analysis. Depending on the development phase, this can be conducted under R&D or cGMP conditions. Our lab employs high-precision instrumentation, such as LC-MS and ELISA, to ensure reliable and reproducible results throughout drug development.
Working with a Method Development Validation Lab ensures that each phase of sample analysis and validation is conducted in line with regulatory requirements, guaranteeing reliable and consistent results across the board. Additionally, analytical method development and validation ensure that all methods used in drug testing are robust, accurate, and reproducible.
Answers to additional Method Development, Validation And Transfer questions popular among our potential clients.
Method development and validation involve creating, optimizing, and verifying analytical methods used to test the identity, purity, potency, and stability of drug substances. It ensures that the method produces accurate, reliable, and reproducible results.
Method validation ensures that analytical methods are reliable, consistent, and suitable for their intended purpose. It is critical in the pharmaceutical industry to meet regulatory standards set by bodies such as the FDA and ICH for the safety and efficacy of drugs.
The steps typically include:
Key parameters include accuracy, precision, specificity, linearity, range, limit of detection (LOD), limit of quantitation (LOQ), robustness, and ruggedness.
The FDA regulates analytical method validation under 21 CFR Part 58 (GLP) and 21 CFR Part 210/211 (cGMP). These regulations ensure that methods used in drug testing are fit for purpose and comply with safety and quality standards.
The International Council for Harmonisation (ICH) provides guidelines (Q2(R1)) for method validation. These cover various aspects of method validation, including accuracy, precision, and specificity.
Method development involves creating and optimizing a method to detect, separate, and quantify analytes, while method validation confirms that the method works reliably and consistently for its intended use.
Common challenges include ensuring the method’s robustness across different matrices, adjusting for sample preparation techniques, and dealing with matrix effects during quantitation.
Commonly used instruments include LC-MS/MS, HPLC, ELISA, and other advanced detection technologies to ensure accurate measurements of drug substances and biomarkers.
The time taken can vary depending on the complexity of the method and the requirements of the validation process, but it typically ranges from a few days to several weeks.
Method development creates and optimizes a method, while method validation confirms the method’s reliability for its intended use.
A Method Development Validation Lab specializes in the creation, optimization, and validation of analytical methods for testing drug substances. These labs ensure that the methods are fit for purpose and compliant with regulatory standards.
Analytical method development and validation are crucial for ensuring that pharmaceutical products are tested for identity, purity, potency, and stability in compliance with regulatory requirements, ensuring drug safety and efficacy.
